Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$4,249,932
+$94,980 QoQ
Shares Held
27,118
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#295
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WOODMONT INVESTMENT COUNSEL LLC holds $91,634,066 across 9 Drug Manufacturers - General names. NVS ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,183 | $26,606,957 | |
| 2 | JNJ |
Johnson & Johnson
|
92,061 | $23,380,732 | |
| 3 | MRK |
Merck & Co., Inc.
|
173,179 | $22,253,501 | |
| 4 | PFE |
Pfizer Inc
|
284,542 | $6,851,771 | |
| 5 | ABBV |
AbbVie Inc.
|
22,718 | $5,716,757 | |
| 6 | NVS |
Novartis AG
This page
|
27,118 | $4,249,932 | |
| 7 | NVO |
Novo Nordisk A S
|
27,438 | $1,315,377 | |
| 8 | AMGN |
Amgen Inc
|
1,805 | $653,626 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,249,932 | 27,118 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $4,154,952 | 27,201 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,838,714 | 27,843 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,617,522 | 28,209 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,207,275 | 34,768 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $3,914,285 | 35,112 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $3,547,338 | 36,454 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,331,423 | 37,658 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $4,086,573 | 38,386 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,837,375 | 39,671 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,910,770 | 38,732 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $4,107,198 | 40,322 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,300,178 | 42,614 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $3,953,056 | 42,968 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $3,931,079 | 43,332 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $3,306,358 | 43,499 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,886,266 | 45,975 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,888,027 | 44,308 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,961,821 | 33,861 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,796,957 | 34,201 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,200,060 | 35,073 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,020,008 | 35,330 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,372,661 | 35,716 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,022,294 | 34,755 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,048,864 | 34,908 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,851,698 | 34,587 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||